We are live on ! Find out more
MSS

Mitchell Sinkler & Starr Portfolio holdings

AUM $240M
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
+24.63%
3 Year Est. Return
+72.22%
5 Year Est. Return
+87.27%
10 Year Est. Return
+266.58%
AUM
$71.3M
AUM Growth
+$7.49M
Cap. Flow
+$6.92M
Cap. Flow %
9.7%
Top 10 Hldgs %
31.49%
Holding
81
New
11
Increased
9
Reduced
32
Closed
2

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$255K
2
GIS icon
General Mills
GIS
+$225K
3
ABBV icon
AbbVie
ABBV
+$170K
4
JNJ icon
Johnson & Johnson
JNJ
+$129K
5
CVX icon
Chevron
CVX
+$122K

Sector Composition

Rank Sector Weight
1 Industrials 14.57%
2 Healthcare 14.09%
3 Consumer Staples 11.96%
4 Energy 9.75%
5 Communication Services 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYY icon
76
Sysco
SYY
$39.7B
$205K 0.29%
+3,700
New +$192K
O icon
77
Realty Income
O
$61.2B
$204K 0.29%
3,659
CASY icon
78
Casey's General Stores
CASY
$31.9B
$203K 0.28%
1,710
FTR
79
DELISTED
Frontier Communications Corp.
FTR
$36K 0.05%
702
-326
-32% -$17.9K
GIS icon
80
General Mills
GIS
$19.2B
-3,525
Closed -$225K
UL icon
81
Unilever
UL
$131B
-4,780
Closed -$255K

Similar funds

Mitchell Sinkler & Starr's Q4 2016 Portfolio in Review

As of Q4 2016, Mitchell Sinkler & Starr held 81 positions worth $71.3M, up 12% from $63.8M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Mitchell Sinkler & Starr deployed $6.92M of net new capital in Q4 2016, opening 11 new positions and adding to 9 existing holdings. Its largest new stake was RPM International: 43,770 shares worth $2.36M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was AbbVie, an estimated $170K trimmed.

  • Mitchell Sinkler & Starr's largest Q4 2016 buy was RPM International: 43,770 shares worth $2.36M.
  • Mitchell Sinkler & Starr added most to Raytheon Company in Q4 2016, an estimated $36.2K increase.
  • Mitchell Sinkler & Starr's biggest Q4 2016 reduction was AbbVie, cutting an estimated $170K.
  • Mitchell Sinkler & Starr fully exited Unilever in Q4 2016, selling an estimated $255K.
  • Mitchell Sinkler & Starr's ten largest holdings make up 31% of its $71.3M portfolio in Q4 2016.
  • Mitchell Sinkler & Starr opened 11 new positions and closed 2 in Q4 2016.
  • Mitchell Sinkler & Starr's portfolio value rose 12% quarter-over-quarter to $71.3M.

Based on Mitchell Sinkler & Starr's 13F filing for Q4 2016, filed 11 Jan 2017.